Evidence map›Paper›PMID 42058505›Full record

ReviewEClinicalMedicine2026

Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications.

Lorenzo Subissi, James R Otieno, Christopher Ruis, Ingrid Rabe, Anurag Agrawal, Laith Jamal Abu-Raddad, Esam I Azhar, Martin Beer, Haroldo Bezerra, Leon Caly and 33 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Lorenzo SubissiHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.
James R OtienoHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.
Christopher RuisVictor Philip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
Ingrid RabeHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.
Anurag AgrawalTrivedi School of Biosciences, Ashoka University, Sonipat, India.
Laith Jamal Abu-RaddadWeill Cornell Medicine-Qatar of Cornell University, Doha, Qatar.
Esam I AzharSpecial Infectious Agents Unit - BSL3, King Fahd Medical Research Center, and Medical Laboratory Sciences Department, King Abdulaziz University, Jeddah, Saudi Arabia.
Martin BeerFriedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald - Insel Riems, Germany.
Haroldo BezerraPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Leon CalyVictorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Meera ChandUK Health Security Agency, London, UK.
Ariamys CompanioniInstitute of Tropical Medicine Pedro Kouri, La Habana, Cuba.
Tulio de OliveiraCentre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.
Isabelle DietrichThe Pirbright Institute, Pirbright, UK.
Christian DrostenCharité Medical Center, Berlin, Germany.
Pablo DuranPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Nuno R FariaSchool of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Adeola FowotadeCollege of Medicine, University of Ibadan, Ibadan, Nigeria.
Lionel GreshPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Baoying HuangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jason KindrachukNational Microbiology Laboratory Branch, Public Health Agency of Canada, Canada.
Marion P G KoopmansVirology Department and Pandemic and Disaster Preparedness Research Centre, Erasmus Medical Centre, Rotterdam, the Netherlands.
Bette KorberLos Alamos National Laboratory, The New Mexico Consortium, Los Alamos, USA.
Yee-Sin LeoNational Centre for Infectious Diseases, Singapore, Singapore.
Placide Mbala-KingebeniInstitut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of the Congo.
Martina McMenaminHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.
Nada M MelhemFaculty of Health Sciences, American University of Beirut, Beirut, Lebanon.
Vincent J MunsterNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Bruno T D NunesEvandro Chagas Institute, Belem, Brazil.
Bas B Oude MunninkVirology Department and Pandemic and Disaster Preparedness Research Centre, Erasmus Medical Centre, Rotterdam, the Netherlands.
Felipe G NavecaLaboratory of Arboviruses and Haemorrhagic Viruses, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.
Malik PeirisSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Gustavo PalaciosDepartment of Microbiology at the Icahn School of Medicine at Mount Sinai, New York, USA.
Paola ResendeLaboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies (LVRE), Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Angel RodriguezPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh.
Tadaki SuzukiDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Andrea VicariPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Anne von GottbergNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Pragya YadavIndian Council of Medical Research - National Institute of Virology, Pune, India.
Jairo Mendez-RicoPan American Health Organisation / World Health Organisation Regional Office for the Americas, Washington DC, USA.
Maria D Van KerkhoveHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.
Diana P RojasHealth Emergencies Programme, World Health Organisation, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically endemic to parts of South America, Oropouche virus (OROV) has caused an estimated 500,000 infections since its discovery, with a marked geographic expansion beyond the Amazon basin into other regions of South America and the Caribbean since late 2023. This Review synthesises current evidence on OROV epidemiology, transmission dynamics, clinical manifestations, diagnostics, viral diversity, and public health impact, with the primary objective of identifying critical knowledge gaps and outlining priorities for surveillance, research, and control. Human transmission occurs primarily via

Indexed as

Emerging arbovirusNeurotropic virusOropouche feverOropouche virusOrthobunyavirusSimbu serogroup

Identifiers

PMID42058505
PMCPMC13121171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.